Return home

MVHS first in Upstate New York to offer Aquablation Therapy

Posted 6/28/22

Mohawk Valley Health System has become the first in Upstate New York to offer Aquablation therapy for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.

This item is available in full to subscribers.

MVHS first in Upstate New York to offer Aquablation Therapy

Posted

Mohawk Valley Health System has become the first in Upstate New York to offer Aquablation therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia.

BPH, or an enlarged prostate, is a non-cancerous condition where the prostate has grown to be larger than normal. One in two men ages 51 to 60 have BPH, and the incidence increases every decade of life. 

If left untreated, BPH can cause significant health problems, including irreversible bladder or kidney damage, bladder stones and incontinence. The problem with BPH surgical treatments today is that they often force men to tradeoff between symptom relief and side effects, limiting patients to choose between either a high degree of symptom relief with high rates of irreversible complications, such as incontinence, erectile dysfunction, or ejaculatory dysfunction, or low degree of symptom relief with low rates of irreversible complications.

Aquablation therapy is a different type of treatment for BPH. It’s an advanced, minimally invasive treatment that uses the power of water delivered with robotic precision to provide best-in-class and long-lasting symptom relief with low rates of irreversible complications, regardless of prostate size or shape.

“We are proud to be among the first in Upstate New York to offer a solution for men with BPH that provides relief without compromise,” said Dr. Hanan Goldberg, chief of Upstate Urology at MVHS. “Aquablation therapy is the next step to furthering our commitment at MVHS to men’s health and new innovations to provide treatments and relief to our community.”

Aquablation therapy is performed by the AquaBeam Robotic System, the first FDA-cleared, surgical robot utilizing automated tissue resection or the treatment of LUTS due to BPH. It combines real-time, multi-dimensional imaging, automated robotic technology, and heat-free waterjet ablation technology for targeted, controlled and immediate removal of prostate tissue. Aquablation therapy offers predictable and reproducible outcomes, independent of prostate anatomy, prostate size or surgeon experience.

Those interested in treatments for BPH, including Aquablation therapy, should speak with their primary care provider. For more information on Aquablation therapy at MVHS, visit mvhealthsytem.org/urology.

Comments

No comments on this item Please log in to comment by clicking here